Detalhe da pesquisa
1.
Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults.
Alzheimers Dement
; 20(1): 376-387, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37639492
2.
Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-ß positive individuals.
Alzheimers Dement
; 20(2): 1166-1174, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920945
3.
Novel avenues of tau research.
Alzheimers Dement
; 20(3): 2240-2261, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170841
4.
Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease.
Alzheimers Dement
; 19(11): 4967-4977, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078495
5.
Comparative analytical performance of multiple plasma Aß42 and Aß40 assays and their ability to predict positron emission tomography amyloid positivity.
Alzheimers Dement
; 2022 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35820077
6.
Replication study of plasma proteins relating to Alzheimer's pathology.
Alzheimers Dement
; 17(9): 1452-1464, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792144
7.
Atherosclerotic plaque uptake of a novel integrin tracer ¹8F-Flotegatide in a mouse model of atherosclerosis.
J Nucl Cardiol
; 21(3): 553-62, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24627345
8.
Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging.
Proc Natl Acad Sci U S A
; 108(35): 14620-5, 2011 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21873245
9.
Personalized whole-brain neural mass models reveal combined Aß and tau hyperexcitable influences in Alzheimer's disease.
Commun Biol
; 7(1): 528, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704445
10.
[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.
Alzheimers Dement
; 9(6): 666-76, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23411393
11.
Revealing the combined roles of Aß and tau in Alzheimer's disease via a pathophysiological activity decoder.
bioRxiv
; 2023 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37502947
12.
A two-step workflow based on plasma p-tau217 to screen for amyloid ß positivity with further confirmatory testing only in uncertain cases.
Nat Aging
; 3(9): 1079-1090, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37653254
13.
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography.
JAMA Neurol
; 80(2): 188-199, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508198
14.
Astrocyte reactivity influences amyloid-ß effects on tau pathology in preclinical Alzheimer's disease.
Nat Med
; 29(7): 1775-1781, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248300
15.
APOEε4 potentiates amyloid ß effects on longitudinal tau pathology.
Nat Aging
; 3(10): 1210-1218, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37749258
16.
Diagnostic and prognostic performance to detect Alzheimer's disease and clinical progression of a novel assay for plasma p-tau217.
Alzheimers Res Ther
; 14(1): 67, 2022 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568889
17.
Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum.
Alzheimers Dement (Amst)
; 14(1): e12307, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35415202
18.
Flow optimization study of a batch microfluidics PET tracer synthesizing device.
Biomed Microdevices
; 13(1): 231-42, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21072595
19.
Development and validation of a high-sensitivity assay for measuring p217+tau in plasma.
Alzheimers Dement (Amst)
; 13(1): e12204, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34095436
20.
Evaluation of [18F]-JNJ-64326067-AAA tau PET tracer in humans.
J Cereb Blood Flow Metab
; 41(12): 3302-3313, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34259071